Nobuyuki Kagiyama, MD

General Statement of Disclosure:

SPEAKER'S BUREAU: Novartis Pharma(MODEST), NIPPON BOEHRINGER INGELHEIM CO., LTD.(MODEST), Otsuka Pharmaceutical Co., Ltd.(MODEST), Bristol-Myers Squibb Company (MODEST), Eli Lilly Japan K.K.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: AstraZeneca Pharmaceuticals(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), AMI Inc.(SIGNIFICANT)

View Full Disclosure